London, 23 September, 2010 – Elsevier is pleased to announce that two of its medical titles won first prize in their respective categories at the annual BMA Medical Book Competition ceremony in London on the 14th September 2010. An additional 22 Elsevier books were highly commended. The Awards were presented by Professor Averil Mansfield, Immediate Past President BMA and Chairman of the BMA Board of Science.
The winning medical titles from Elsevier are:
"Congratulations and warmest thanks to all of the authors, editors, and Elsevier publishing staff who worked on these prize-winning titles," remarked Linda Belfus, Senior Vice President, Global Clinical Reference. "This is an amazing achievement and reflects Elsevier's dedication to developing and delivering quality content across the healthcare spectrum."
About the British Medical Association Awards
The BMA Medical Book Competition has been held annually since 1994 by the BMA's Board of Science and administered by the BMA Library. It aims to encourage and reward excellence in medical publishing and patient information.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet ( www.thelancet.com ) and Cell ( www.cell.com ), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect ( www.sciencedirect.com ), Scopus ( www.scopus.com ), Reaxys ( www.reaxys.com ), MD Consult ( www.mdconsult.com ) and Nursing Consult ( www.nursingconsult.com ), which enhance the productivity of science and health professionals, and the SciVal suite ( www.scival.com ) and MEDai's Pinpoint Review ( www.medai.com ), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier ( www.elsevier.com ) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC ( www.reedelsevier.com ), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).